Caidya

Caidya is a global, full-service CRO delivering personalized clinical development solutions across all phases of clinical research. The company specializes in early-phase development, Phase II/III studies, and clinical operations with deep expertise in oncology & hematology, rare diseases, dermatology, cell and gene therapy, cardiology, gastroenterology, infectious diseases, nephrology, neurology, pediatrics, respiratory, and women's health.

Core Services:

• Clinical Development: Early phase development, Phase II/III studies, and clinical development expertise
• Clinical Operations & Delivery: Study start-up, patient pathway & feasibility assessment
• Regulatory Services & Surveillance: Regulatory services, pharmacovigilance, and medical writing
• Data & Technology: Biometrics and biostatistics, clinical analytics, clinical data management, clinical technology ecosystem, RBQM, and AI principles
• Quality Assurance: Best-in-class QA ensuring compliance with ICH/GCP standards and regulatory requirements across regions including FDA, MHRA, AIFA, and TFDA

Differentiation: Caidya emphasizes patient-centric solutions, global reach across 40+ countries and regions, and agile partnership models. The company operates with a transparent, collaborative approach, leveraging its Clarity platform to synthesize data across technology ecosystems for near real-time trial visibility. Leadership is actively engaged and accessible. The organization maintains a robust, harmonized Quality Management System with extensive experience in regulatory inspections and audit management.